Saugar Maripuri1, T Alp Ikizler, Kerri L Cavanaugh. 1. Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Abstract
BACKGROUND/AIMS: Pre-end-stage renal disease (ESRD) care is associated with improved outcomes among patients receiving dialysis. It is unknown what proportion of US micropolitan and rural dialysis patients receive pre-ESRD care and benefit from such care when compared to urban. METHODS: A retrospective cohort study was performed using data from the US Renal Data System. Patients ≥18 years old who initiated dialysis in 2006 and 2007 were classified as rural, micropolitan or urban and the prevalence of pre-ESRD care (early nephrology care >6 months, permanent vascular access, -dietary education) was determined using the medical evidence report. The association of pre-ESRD care with dialysis mortality and transplantation was assessed using Cox regression with stratification for geographic residence. RESULTS: Of 204,463 dialysis patients, 80% were urban, 10.2% were micropolitan and 9.8% were rural. Overall attainment of pre-ESRD care was poor. After adjustment, there were no significant geographic differences in attainment of early nephrology care or permanent dialysis access. Receiving care reduced all-cause mortality and increased the likelihood of transplantation to a similar degree regardless of geographic residence. Both micropolitan and rural patients received less dietary education (relative risk = 0.80, 95% CI = 0.76-0.84 and relative risk = 0.85, 95% CI = 0.80-0.89, respectively). CONCLUSION: Among patients who receive dialysis, the prevalence of early nephrology care and permanent dialysis access is poor and does not vary by geographic residence. Micropolitan and rural patients receive less dietary education despite an observed mortality benefit, suggesting that barriers may exist to quality dietary care in more remote locations.
BACKGROUND/AIMS: Pre-end-stage renal disease (ESRD) care is associated with improved outcomes among patients receiving dialysis. It is unknown what proportion of US micropolitan and rural dialysis patients receive pre-ESRD care and benefit from such care when compared to urban. METHODS: A retrospective cohort study was performed using data from the US Renal Data System. Patients ≥18 years old who initiated dialysis in 2006 and 2007 were classified as rural, micropolitan or urban and the prevalence of pre-ESRD care (early nephrology care >6 months, permanent vascular access, -dietary education) was determined using the medical evidence report. The association of pre-ESRD care with dialysis mortality and transplantation was assessed using Cox regression with stratification for geographic residence. RESULTS: Of 204,463 dialysis patients, 80% were urban, 10.2% were micropolitan and 9.8% were rural. Overall attainment of pre-ESRD care was poor. After adjustment, there were no significant geographic differences in attainment of early nephrology care or permanent dialysis access. Receiving care reduced all-cause mortality and increased the likelihood of transplantation to a similar degree regardless of geographic residence. Both micropolitan and rural patients received less dietary education (relative risk = 0.80, 95% CI = 0.76-0.84 and relative risk = 0.85, 95% CI = 0.80-0.89, respectively). CONCLUSION: Among patients who receive dialysis, the prevalence of early nephrology care and permanent dialysis access is poor and does not vary by geographic residence. Micropolitan and rural patients receive less dietary education despite an observed mortality benefit, suggesting that barriers may exist to quality dietary care in more remote locations.
Authors: Nakela L Cook; LeRoi S Hicks; A James O'Malley; Thomas Keegan; Edward Guadagnoli; Bruce E Landon Journal: Health Aff (Millwood) Date: 2007 Sep-Oct Impact factor: 6.301
Authors: P Arora; G T Obrador; R Ruthazer; A T Kausz; K B Meyer; C S Jenuleson; B J Pereira Journal: J Am Soc Nephrol Date: 1999-06 Impact factor: 10.121
Authors: Catherine Sullivan; Srilekha S Sayre; Janeen B Leon; Rhoderick Machekano; Thomas E Love; David Porter; Marquisha Marbury; Ashwini R Sehgal Journal: JAMA Date: 2009-02-11 Impact factor: 56.272
Authors: Laura C Plantinga; Min Kim; Margarethe Goetz; David G Kleinbaum; William McClellan; Rachel E Patzer Journal: Am J Nephrol Date: 2014-01-15 Impact factor: 3.754
Authors: J D Schold; E L G Heaphy; L D Buccini; E D Poggio; T R Srinivas; D A Goldfarb; S M Flechner; J R Rodrigue; J D Thornton; A R Sehgal Journal: Am J Transplant Date: 2013-08-22 Impact factor: 8.086
Authors: Laura Plantinga; Stephen Pastan; Michael Kramer; Ann McClellan; Jenna Krisher; Rachel E Patzer Journal: Am J Nephrol Date: 2014-09-02 Impact factor: 3.754
Authors: Brian M Brady; Bo Zhao; Jingbo Niu; Wolfgang C Winkelmayer; Arnold Milstein; Glenn M Chertow; Kevin F Erickson Journal: JAMA Intern Med Date: 2018-10-01 Impact factor: 21.873
Authors: Nicole Jane Scholes-Robertson; Talia Gutman; Martin Howell; Jonathan Craig; Rachel Chalmers; Karen M Dwyer; Matthew Jose; Ieyesha Roberts; Allison Tong Journal: BMJ Open Date: 2022-02-17 Impact factor: 2.692
Authors: Nicole Jane Scholes-Robertson; Martin Howell; Talia Gutman; Amanda Baumgart; Victoria SInka; David J Tunnicliffe; Stephen May; Rachel Chalmers; Jonathan Craig; Allison Tong Journal: BMJ Open Date: 2020-09-23 Impact factor: 2.692